Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk and ER-Positive DCIS
NCT04046159Phase 3Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2019
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tamoxifen in ductal carcinoma in situ (DCIS), sponsored by National Taiwan University Hospital. Started Apr 2019; status: recruiting.
02
Drugs
tamoxifen
03
Conditions
ductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT04046159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04046159.